論壇議程總覽
2025 Satellite Symposia
Jul.23
從數據驅動到臨床價值，加速癌症治療實踐健康台灣願景
Room 701F, Hall 2
Date / Time :July 23 13:30-16:00
Venue : Taipei Nangang Exhibition Center, Hall 2 (Room 701F)
Jul.24
LumiSTAR & Molecular Devices Session
Room 402C, Hall 1
Date / Time :July 24 13:00-17:00
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 402C)
Jul.24
Treg Symposium 2025
Engineering Immune Peace: Translating Treg Science into Clinical Reality
Room 403, Hall 1
Date / Time : July 24 08:00-17:00
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 403)
Co-organizer : Taiwan Bio Therapeutics INC.
| Time | Topic | Speaker |
|---|---|---|
| 08:00-08:30 | Registration | |
| 08:30-09:00 | Opening Remarks | Session Chair: Cyrus Yang |
| 09:00-10:00 | Discovery of New Immunotherapy Targets and Mechanisms Leveraging CRISPR | Arlene H. Sharpe Kolokotrones University Professor｜Harvard Medical School |
| 10:00-10:30 | Coffee Break | |
| 10:30-11:30 | Tfr Regulation of Antibody Mediated Diseases | Peter T. Sage Associate Professor of Medicine｜Harvard Medical School and Brigham and Women's Hospital |
| 11:30-13:00 | Lunch Break | |
| 13:00-14:00 | Therapy in Autoimmunity with a Focus on Inflammatory Bowel Disease | William A. Faubion Dean of Research, MCA｜Mayo Clinic Executive Medical Director, CRB｜Mayo Clinic |
| 14:00-15:00 | Polymeric Particles for Immunomodulation | Jordan J. Green Herschel L. Seder Professor of Biomedical Engineering｜Johns Hopkins University School of Medicine |
| 15:00-15:20 | Coffee Break | |
| 15:20-16:20 | Industry Perspective: Polyclonal Regulatory T Cell Therapy in Solid Organ Transplantation Clinical Trials |
Cyrus Yang |
| 16:20-17:00 | Panel Discussion & Concluding Remarks | Moderator: Dr. Cyrus Yang Panelists: Arlene H. Sharpe, Peter T. Sage, William A. Faubion, Jordan J. Green |
Regulatory T cells (Tregs) have long been recognized as central mediators of immune tolerance. What distinguishes the current moment in the field is the maturity of science and technology, which now makes it possible to translate decades of discovery into real therapeutic opportunities. With growing momentum in clinical trials and the advent of genetic engineering to enhance Treg stability, specificity, and function, Treg-based therapies are rapidly evolving from concept to clinic—offering new hope for patients with autoimmune diseases and for preventing transplant rejection.
Treg Symposium 2025 offers a timely and focused platform to explore these advances. By bringing together leading experts from both academia and industry, the symposium fosters the kind of interdisciplinary dialogue essential for addressing the scientific, clinical, and manufacturing challenges of Treg therapy. Topics will span from cutting-edge tools for understanding Treg biology and discovering new therapeutic opportunities, to clinical-stage developments of ex vivo Treg therapies and emerging strategies for in vivo Treg modulation.
Jul.24
Promega Session-Innovating Biologics: Accelerating Drug Discovery and Development with Functional Bioassays
Room 503, Hall 1
Date / Time : July 24 13:00–17:30
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 503)
Co-organizer : Promega Corporation
| Time | Topic | Speaker |
|---|---|---|
| 13:00-13:30 |
Registration |
|
| 13:30 |
Opening |
LayPing Lee |
| 13:35-14:20 |
Illuminating Biologics Drug Discovery with Innovative Assays |
Dr. Frank Fan |
| 14:20-15:20 |
The Bioluminescent Toolbox for Vaccine Characterization and mRNA Quality Control |
Dr. Jamison Grailer |
| 15:20-15:50 |
Promega Bioassays: Enabling Reliable Methodology for Research and Industrial Advancement |
Dr. Mei-Wei Lin |
| 15:50-16:00 |
Break |
|
| 16:00-16:30 |
Bioassays Development for Product Release and Characterization - From a CDMO Perspective |
Dr. Toby Hong |
| 16:30-17:20 |
Bioluminescent Platform Technologies for Functional Characterization of Advanced Cancer Therapeutics |
Dr. Jamison Grailer |
| 17:20 |
Closing |
Dr. Frank Fan |
Jul.25
加速審查發表會
Room 504A, Hall 1
Date / Time : July 24 13:00-17:00
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 504A)
Date / Time : July 25 14:00-17:00
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 402AB)
Co-organizer: Genetics Generation Advancement Corp訊聯基因數位股份有限公司、Taiwan Bio Industry Organization社團法人台灣生物產業發展協會
| Time | Topic | Speaker |
|---|---|---|
| 14:00-14:30 |
來賓報到 |
|
| 14:30-14:45 |
貴賓致詞 |
|
| 14:45-15:15 |
AI解碼生物訊號：從胜肽、外泌體到細胞的創新藥物開發方法 |
蔡耿彰 教授 |
| 15:15-15:45 |
AI賦能藥品研發與實驗室自動化：加速藥品品質管理與生產製程革新 |
華鵬 |
| 15:45-15:50 |
Q&A |
|
| 15:50-16:10 |
AI智慧製藥實踐轉型路徑：電子批次紀錄引領製藥製程與品質變革 |
Jack Lim |
| 16:10-17:00 |
AI Demo Time |
|
Session Synopsis:
在全球AI時代的到來，AI技術正加速驅動從藥物設計、品質控管到製造生產的整體革新。本論壇以「AI賦能 智藥時代：藥物設計 × 品質 × 製造整合實踐」為主題，聚焦AI於生技製藥領域的多面向應用與成功實例，集結來自國內外專家，包含衛福部國家中醫藥研究所、達梭系統、MasterControl等領先單位， 共同剖析AI如何成為生技製藥產業的關鍵推進力、實踐潛力與未來機會。
本次論壇涵蓋三大亮點議題：
議題一、AI解碼生物訊號：從胜肽、外泌體到細胞的創新藥物開發方法
議題二、AI賦能藥品研發與實驗室自動化：加速藥品品質管理與生產製程革新
議題三、AI智慧製藥實踐轉型路徑：電子批次紀錄引領製藥製程與品質變革
謹代表訊聯集團誠摯邀請製藥廠、生技企業先進，CRDMO廠商與藥界學研機構共同參與。
Jul.25
Breaking into the U.S. Healthcare Innovation Market
Room 404, Hall 1
Jul.25
Digital and Automated Cell Manufacturing: From QbD to AI and Robotics
Room 503, Hall 1
Date / Time : July 25 13:30–17:00
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 503)
Co-organizer : Purple Win Co., Ltd.
| Time | Topic | Speaker |
|---|---|---|
| 13:30–14:00 |
Registration |
|
| 14:00–14:10 |
Opening Remarks |
Session Chair |
| 14:10–15:10 |
Advanced Morphological AI Analysis as a Process Analytical Technology for Quality by Design–Driven Process Development |
Ryuji Kato Associate Professor, Nagoya University, Tokai National Higher Education and Research System
|
| 15:10–15:30 |
Coffee Break |
|
| 15:30–15:40 |
2nd Opening Remark |
|
| 15:40–16:40 |
Development of robotic automation system for cell manufacturing |
Masahiro Kino-oka Professor, Department of Biotechnology, The University of Osaka
|
| 16:40–17:00 |
Closing Discussion |